Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Hansen, H H"'
Autor:
Evald Hoej Christiansen, Jan Ravkilde, Hans-Henrik Tilsted, Anton Boel Villadsen, Lars Romer Krusell, Per Thayssen, Lisette Okkels Jensen, Knud Erik Pedersen, Michael Maeng, Hans Erik Bøtker, Jens Flensted Lassen, Knud Noerregaard Hansen, Thomas Vesterlund, Leif Thuesen, Jens Aarøe
Publikováno v:
Jensen, L O, Maeng, M, Thayssen, P, Villadsen, A, Krusell, L R, Botker, H E, Pedersen, K E, Aaroe, J, Christiansen, E H, Vesterlund, T, Hansen, K N, Ravkilde, J, Hansen, H-H T, Lassen, J F & Thuesen, L 2011, ' Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial ', EuroIntervention, vol. 7, no. 3, pp. 323-31 . https://doi.org/10.4244/EIJV7I3A56
Jensen, L O, Mæng, M, Thayssen, P, Boel Villadsen, A, Krusell, L R, Botker, H E, Pedersen, K E, Aaroe, J, Christiansen, E H, Vesterlund, T, Hansen, K N, Ravkilde, J, Hansen, H-H T, Lassen, J F & Thuesen, L 2011, ' Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial ', EuroIntervention, vol. 7, no. 3, pp. 323-31 . https://doi.org/10.4244/EIJV7I3A56
Jensen, L O, Mæng, M, Thayssen, P, Boel Villadsen, A, Krusell, L R, Botker, H E, Pedersen, K E, Aaroe, J, Christiansen, E H, Vesterlund, T, Hansen, K N, Ravkilde, J, Hansen, H-H T, Lassen, J F & Thuesen, L 2011, ' Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial ', EuroIntervention, vol. 7, no. 3, pp. 323-31 . https://doi.org/10.4244/EIJV7I3A56
Aims: Patients with diabetes mellitus have increased risk of in-stent restenosis after coronary stent implantation due to neointimal hyperplasia (NIH). The aim of this study was to use quantitative coronary angiography (QCA) and volumetric intravascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b64b58000baad493520c21bfcb40b360
https://portal.findresearcher.sdu.dk/da/publications/4d8365fa-73b8-4b14-9a89-1f41971b32ca
https://portal.findresearcher.sdu.dk/da/publications/4d8365fa-73b8-4b14-9a89-1f41971b32ca
Autor:
Lars Romer Krusell, Leif Thuesen, Henrik Toft Sørensen, Hans-Henrik Tilsted Hansen, Lars Pedersen, Jens Flensted Lassen, Anne Kaltoft, Morten Bøttcher, Per Thayssen, Søren Paaske Johnsen, Klaus Rasmussen, Lisette Okkels Jensen, Michael Maeng
Publikováno v:
Maeng, M, Jensen, L O, Kaltoft, A, Hansen, H H T, Bøttcher, M, Lassen, J F, Thayssen, P, Krusell, L R, Rasmussen, K, Pedersen, L, Sørensen, H T, Johnsen, S P & Thuesen, L 2008, ' Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus ', American Journal of Cardiology, vol. 102, no. 2, pp. 165-172 . https://doi.org/10.1016/j.amjcard.2008.03.034
Maeng, M, Jensen, L O, Kaltoft, A, Hansen, H-H T, Bøttcher, M, Lassen, J F, Thayssen, P, Krusell, L R, Rasmussen, K, Pedersen, L, Sørensen, H T, Johnsen, S P & Thuesen, L 2008, ' Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus. ', American Journal of Cardiology, vol. 102, no. 2, pp. 165-72 . https://doi.org/10.1016/j.amjcard.2008.03.034
Maeng, M, Jensen, L O, Kaltoft, A, Hansen, H H T, Bøttcher, M, Lassen, J F, Thayssen, P, Krusell, L R, Rasmussen, K, Pedersen, L, Sørensen, H T, Johnsen, S P & Thuesen, L 2008, ' Comparison of Stent Thrombosis, Myocardial Infarction, and Mortality Following Drug-Eluting Versus Bare-Metal Stent Coronary Intervention in Patients With Diabetes Mellitus ', American Journal of Cardiology, vol. 102, no. 2, pp. 165-172 . https://doi.org/10.1016/j.amjcard.2008.03.034
Maeng, M, Jensen, L O, Kaltoft, A, Hansen, H-H T, Bøttcher, M, Lassen, J F, Thayssen, P, Krusell, L R, Rasmussen, K, Pedersen, L, Sørensen, H T, Johnsen, S P & Thuesen, L 2008, ' Comparison of stent thrombosis, myocardial infarction, and mortality following drug-eluting versus bare-metal stent coronary intervention in patients with diabetes mellitus. ', American Journal of Cardiology, vol. 102, no. 2, pp. 165-72 . https://doi.org/10.1016/j.amjcard.2008.03.034
Maeng, M, Jensen, L O, Kaltoft, A, Hansen, H H T, Bøttcher, M, Lassen, J F, Thayssen, P, Krusell, L R, Rasmussen, K, Pedersen, L, Sørensen, H T, Johnsen, S P & Thuesen, L 2008, ' Comparison of Stent Thrombosis, Myocardial Infarction, and Mortality Following Drug-Eluting Versus Bare-Metal Stent Coronary Intervention in Patients With Diabetes Mellitus ', American Journal of Cardiology, vol. 102, no. 2, pp. 165-172 . https://doi.org/10.1016/j.amjcard.2008.03.034
Udgivelsesdato: 2008-Jul-15 The aim of this study was to examine outcomes subsequent to implantation of drug-eluting stents (DESs) and bare-metal stents (BMSs) in patients with diabetes. From January 2002 to June 2005, data from all percutaneous coro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eea71d4f3444a949cb9d01f13640677
https://portal.findresearcher.sdu.dk/da/publications/0c329980-4763-11dd-9fbe-000ea68e967b
https://portal.findresearcher.sdu.dk/da/publications/0c329980-4763-11dd-9fbe-000ea68e967b
Autor:
Erik Lerkevang Grove, Steen Dalby Kristensen, Anne Kaltoft, Lisette Okkels Jensen, Anne-Mette Hvas, Hans H. Tilsted, Morten Würtz, Lise N. Wulff
Publikováno v:
Würtz, M, Grove, E, Wulff, L N, Kaltoft, A, Hansen, H-H T, Jensen, L O, Hvas, A-M & Kristensen, S D 2010, ' Patients With Previous Definite Stent Thrombosis Have a Larger Fraction of Immature Platelets and a Reduced Antiplatelet Effect of Aspirin ', Århus, Denmark, 15/01/2010, .
Würtz, M, Grove, E, Wulff, L N, Kaltoft, A, Hansen, H-H T, Jensen, L O, Hvas, A-M & Kristensen, S D 2010, ' Patients with previous definite stent thrombosis have a larger fraction of immature platelets and a reduced antiplatelet effect of aspirin ' Journal of the American College of Cardiology, Atlanta, USA, 09/03/2010-09/03/2010, .
Würtz, M, Grove, E, Wulff, L N, Kaltoft, A, Hansen, H-H T, Jensen, L O, Hvas, A-M & Kristensen, S D 2010, ' Patients with previous definite stent thrombosis have a larger fraction of immature platelets and a reduced antiplatelet effect of aspirin ' Journal of the American College of Cardiology, Atlanta, USA, 09/03/2010-09/03/2010, .
Objectives This study sought to evaluate the platelet response to aspirin and the immature platelet fraction in patients with previous stent thrombosis (ST). Background ST is a potentially fatal complication of coronary stenting. A reduced platelet r
Autor:
Urmas Roostalu, Kristoffer T.G. Rigbolt, Casper Gravesen Salinas, Johanna Perens, Niels Vrang, Pernille Barkholt, Jacob Lercke Skytte, Ditte Dencker Thorbek, Jacob Hecksher-Sørensen, Henrik H. Hansen, Jacob Jelsing
Publikováno v:
Hansen, H H, Perens, J, Roostalu, U, Skytte, J L, Salinas, C B G, Barkholt, P, Thorbek, D D, Rigbolt, K T G, Vrang, N, Jelsing, J & Hecksher-Sørensen, J 2021, ' Whole-brain activation signatures of weightlowering drugs ', Molecular Metabolism, vol. 47, 101171 . https://doi.org/10.1016/j.molmet.2021.101171
Molecular Metabolism, Vol 47, Iss, Pp 101171-(2021)
Molecular Metabolism
Molecular Metabolism, Vol 47, Iss, Pp 101171-(2021)
Molecular Metabolism
Objective The development of effective anti-obesity therapeutics relies heavily on the ability to target specific brain homeostatic and hedonic mechanisms controlling body weight. To obtain further insight into neurocircuits recruited by anti-obesity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8024f93f404dc470a060e22639291c38
https://orbit.dtu.dk/en/publications/b3ee5cba-b147-4bb0-b632-6506b3a611a7
https://orbit.dtu.dk/en/publications/b3ee5cba-b147-4bb0-b632-6506b3a611a7
Autor:
Mette Simone Aae Madsen, Niels Vrang, Kristoffer T.G. Rigbolt, Martin Tue Mikkelsen, Rikke Veggerby Grønlund, Henrik H. Hansen, John Eid, Martin R. Madsen, Jacob Jelsing, Mikkel Christensen-Dalsgaard, Morten Otto Alexander Sommer
Publikováno v:
Madsen, M S A, Grønlund, R V, Eid, J, Christensen-Dalsgaard, M, Sommer, M O A, Rigbolt, K, Madsen, M R, Jelsing, J, Vrang, N, Hansen, H H & Mikkelsen, M T 2021, ' Characterization of local gut microbiome and intestinal transcriptome responses to rosiglitazone treatment in diabetic db/db mice ', Biomedicine and Pharmacotherapy, vol. 133, 110966 . https://doi.org/10.1016/j.biopha.2020.110966
Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 110966-(2021)
Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 110966-(2021)
The gut microbiota has been implicated in the therapeutic effects of antidiabetics. It is unclear if antidiabetics directly influences gut microbiome-host interaction. Oral peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists, such as ros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f2e00c6d1ca24a3497296877eebe2d
https://orbit.dtu.dk/en/publications/c7ed2afc-ed03-48cc-bf2f-189dd40a0a6b
https://orbit.dtu.dk/en/publications/c7ed2afc-ed03-48cc-bf2f-189dd40a0a6b
Autor:
Mette Simone Aae Madsen, Jacob Bak Holm, Morten Otto Alexander Sommer, Jacob Jelsing, Niels Vrang, Katrine Fabricius, Henrik H. Hansen, Kristoffer T. G. Rigbolt, Pernille Wismann, Albert Pallejà, Martin Tue Mikkelsen, Henrik Nielsen
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports
Madsen, M S A, Holm, J B, Pallejà, A, Wismann, P, Fabricius, K, Rigbolt, K, Mikkelsen, M T, Sommer, M O A, Jelsing, J, Nielsen, H B, Vrang, N & Hansen, H H 2019, ' Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice ', Scientific Reports, vol. 9, 15582 . https://doi.org/10.1038/s41598-019-52103-x
Scientific Reports
Madsen, M S A, Holm, J B, Pallejà, A, Wismann, P, Fabricius, K, Rigbolt, K, Mikkelsen, M T, Sommer, M O A, Jelsing, J, Nielsen, H B, Vrang, N & Hansen, H H 2019, ' Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice ', Scientific Reports, vol. 9, 15582 . https://doi.org/10.1038/s41598-019-52103-x
Enteroendocrine L-cell derived peptide hormones, notably glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2), have become important targets in the treatment of type 2 diabetes, obesity and intestinal diseases. As gut microbial imbalan
Autor:
Jacob Jelsing, Philip J. Pedersen, Stefan Theis, Uwe Schwahn, Thorsten Schmidt, Niels Vrang, Anders Hay-Schmidt, Maria Luisa Fernandez-Cachon, Kristoffer T. G. Rigbolt, Henrik H. Hansen, Thomas Hübschle, Mechthilde Falkenhahn, Pernille Barkholt
Publikováno v:
Barkholt, P, Rigbolt, K T G, Falkenhahn, M, Huebschle, T, Schwahn, U, Fernandez-Cachon, M L, Schmidt, T, Theis, S, Hansen, H H, Hay-Schmidt, A, Pedersen, P J, Vrang, N & Jelsing, J 2019, ' Global transcriptome analysis of rat hypothalamic arcuate nucleus demonstrates reversal of hypothalamic gliosis following surgically and diet induced weight loss ', Scientific Reports, vol. 9, 16161 . https://doi.org/10.1038/s41598-019-52257-8
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports
The central mechanisms underlying the marked beneficial metabolic effects of bariatric surgery are unclear. Here, we characterized global gene expression in the hypothalamic arcuate nucleus (Arc) in diet-induced obese (DIO) rats following Roux-en-Y g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42436930ca18a59a382e983a69b26808
https://curis.ku.dk/ws/files/232004498/Global_transcriptome_analysis_of_rat_hypothalamic_arcuate_nucleus_demonstrates_reversal_of_hypothalamic_gliosis_following_surgically_and_diet_induced_weight_loss.pdf
https://curis.ku.dk/ws/files/232004498/Global_transcriptome_analysis_of_rat_hypothalamic_arcuate_nucleus_demonstrates_reversal_of_hypothalamic_gliosis_following_surgically_and_diet_induced_weight_loss.pdf
Autor:
Morten Skovgaard Jensen, Andreas Søderman, Morten S. Thomsen, Henrik H. Hansen, Mark J. West, Nielsen Elsebet Ostergaard, Jens D. Mikkelsen
Publikováno v:
Aarhus University
Søderman, A, Thomsen, M S, Hansen, H H, Nielsen, E Ø, Jensen, M S, West, M J & Mikkelsen, J D 2008, ' The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice oxerexpressing human amyloid-beta 1-42 ', Brain Research, vol. 1227, pp. 240-47 .
Søderman, A, Thomsen, M S, Hansen, H H, Nielsen, E Ø, Jensen, M S, West, M J & Mikkelsen, J D 2008, ' The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-beta1-42 ', Gene Expression Patterns, vol. 1227, pp. 240-7 . https://doi.org/10.1016/j.brainres.2008.06.062
Søderman, A, Thomsen, M S, Hansen, H H, Nielsen, E Ø, Jensen, M S, West, M J & Mikkelsen, J D 2008, ' The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice oxerexpressing human amyloid-beta 1-42 ', Brain Research, vol. 1227, pp. 240-47 .
Søderman, A, Thomsen, M S, Hansen, H H, Nielsen, E Ø, Jensen, M S, West, M J & Mikkelsen, J D 2008, ' The nicotinic alpha7 acetylcholine receptor agonist ssr180711 is unable to activate limbic neurons in mice overexpressing human amyloid-beta1-42 ', Gene Expression Patterns, vol. 1227, pp. 240-7 . https://doi.org/10.1016/j.brainres.2008.06.062
Recent studies have demonstrated that amyloid-beta1-42 (Abeta1-42) binds to the nicotinergic alpha7 acetylcholine receptor (alpha7 nAChR) and that the application of Abeta1-42 to cells inhibits the function of the alpha7 nAChR. The in vivo consequenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8aee4008e85679d3f6a5ea57185b535
https://pure.au.dk/portal/en/publications/the-nicotinic-alpha7-acetylcholine-receptor-agonist-ssr180711-is-unable-to-activate-limbic-neurons-in-mice-oxerexpressing-human-amyloidbeta-142(f48f7dc0-1a85-11dd-afca-000ea68e967b).html
https://pure.au.dk/portal/en/publications/the-nicotinic-alpha7-acetylcholine-receptor-agonist-ssr180711-is-unable-to-activate-limbic-neurons-in-mice-oxerexpressing-human-amyloidbeta-142(f48f7dc0-1a85-11dd-afca-000ea68e967b).html
Autor:
James Williamson, Ole N. Jensen, Jens D. Mikkelsen, Henrik H. Hansen, Pawel Palmowski, Adelina Rogowska-Wrzesinska, Hans Christian Beck
Publikováno v:
Palmowski, P, Rogowska-Wrzesinska, A, Williamson, J, Beck, H C, Mikkelsen, J D, Hansen, H H & Jensen, O N 2014, ' Acute phencyclidine treatment induces extensive and distinct protein phosphorylation in rat frontal cortex ', Journal of Proteome Research, vol. 13, no. 3, pp. 1578-1592 . https://doi.org/10.1021/pr4010794
Phencyclidine (PCP), a noncompetitive N-methyl-d-aspartate receptor antagonist, induces psychotomimetic effects in humans and animals. Administration of PCP to rodents is used as a preclinical model for schizophrenia; however, the molecular mechanism
Autor:
Lisette Okkels, Jensen, Per, Thayssen, Henrik Steen, Hansen, Evald Høj, Christiansen, Hans Henrik, Tilsted, Lars Romer, Krusell, Anton Boel, Villadsen, Anders, Junker, Knud Nørregaard, Hansen, Anne, Kaltoft, Michael, Maeng, Knud Erik, Pedersen, Steen Dalby, Kristensen, Hans Erik, Bøtker, Jan, Ravkilde, Richardo, Sanchez, Jens, Aarøe, Morten, Madsen, Henrik Toft, Sørensen, Leif, Thuesen, Jens Flensted, Lassen
Publikováno v:
Okkels Jensen, L, Thayssen, P, Hansen, H S, Christiansen, E H, Hansen, H-H T, Krusell, L R, Boel Villadsen, A, Junker, A, Nørregaard Hansen, K, Kaltoft, A, Maeng, M, Pedersen, K E, Kristensen, S D, Bøtker, H E, Ravkilde, J, Sanchez, R, Aarøe, J, Madsen, M, Sørensen, H T, Thuesen, L, Lassen, J F & for the Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV) Investigators 2012, ' Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention: The Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV) ', Circulation, vol. 125, no. 10, pp. 1246-1255 . https://doi.org/10.1161/CIRCULATIONAHA.111.063644
Background— Among drug-eluting stents released to date, the sirolimus-eluting stent has demonstrated the least amount of late lumen loss, but its efficacy and safety have not been compared head-to-head with the next-generation everolimus-eluting st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b04d52b424cef6faaf98411355586b2e
https://portal.findresearcher.sdu.dk/da/publications/4f47db34-7ba1-4d57-9232-c6818fabb493
https://portal.findresearcher.sdu.dk/da/publications/4f47db34-7ba1-4d57-9232-c6818fabb493